Deliver Your News to the World

Rottenstein Law Group Looking Forward to Fosamax Multidistrict Litigation Progress After Formation of Steering Committee


(New York, NY, August 8, 2011) The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is anticipating progress in the multidistrict litigation proceedings following the formation of a steering committe.

The federal court, handling multiple Fosamax cases with regard to pre-trial matters, last month established leadership committees of counsel and assigned certain plaintiffs’ lawyers to those committees. Case Management Order No. 3 in Civil Action No. 08-08, In Re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II), was signed by the Honorable Garrett E. Brown, United States District Judge, of the United States District Court for the District of New Jersey on July 14.

The order established a Plaintiffs’ Steering Committee, designating eleven attorneys from firms in eight different states to serve on the committee. The Steering Committee will be responsible for coordinating the plaintiffs’ activities during pre-trial proceedings.
The United States Panel on Multidistrict Litigation had previously, by an order dated May 23, 2011, in case number MDL 2243, ordered that 36 actions against defendant Merck, Sharp & Dohme Corp. (formerly Merck & Co.), pending in eight federal districts, be consolidated in the United States District Court for the District of New Jersey and, if possible, assigned there to Judge Brown.

The U.S. Food and Drug Administration (FDA) issued a Fosamax warning in October 2010, stating that bisphosphonates cause rare low-impact femur fractures. Dozens of lawsuits were filed against the manufacturer in various federal courts after the warning was issued. The suits allege, among other things, that Merck failed to not only adequately test the drug, but to also warn users of its dangers.

The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.

About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.


 femur fractures

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.